2019.7.8 TSH Biopharm working together with InnoPharmax and Shandong Newtime Pharmacutical enter into global agreement of
...
More
2019.7.18 Taiwan Healthcare & Life Sciences Review 2019-Interview with Grace Yang, General Manager of TSH Biopharm
2019.6.26 The Bridging study of RNTA06, which is indicated for the treatment of chronic angina, is completed and unblended,
2019.2.13 TSH Biopharm acquires the commercialization right of all CellMax Life liquid-biopsy diagnosis products